Invesco Portfolio holdings
Invesco Ltd., founded in 1978 and headquartered in Atlanta, Georgia, is a global investment management firm managing hundreds of billions in assets across a diverse range of products, including mutual funds, exchange-traded funds (ETFs), and institutional portfolios. Known for its blend of active and passive investment strategies, Invesco serves individual investors, financial advisors, and institutions, with a strong presence in North America, Europe, and Asia, bolstered by acquisitions like OppenheimerFunds in 2019. The firm offers specialized solutions in equities, fixed income, real estate, and alternatives, leveraging its global research capabilities to cater to varying market needs. Invesco’s commitment to innovation and client-focused investing has solidified its reputation as a versatile player in the asset management industry.
Top Buys
| 1 |
HEICO Class A
HEI.A
|
+$914M |
| 2 |
UnitedHealth
UNH
|
+$677M |
| 3 |
Ferguson
FERG
|
+$652M |
| 4 |
Apple
AAPL
|
+$642M |
| 5 |
Visa
V
|
+$628M |
Top Sells
| 1 |
Vale
VALE
|
+$940M |
| 2 |
Pinduoduo
PDD
|
+$546M |
| 3 |
Meta Platforms (Facebook)
META
|
+$418M |
| 4 |
Mid-America Apartment Communities
MAA
|
+$369M |
| 5 |
NetEase
NTES
|
+$330M |
Sector Composition
| 1 | Technology | 19.91% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.68% |
| 4 | Consumer Discretionary | 10.55% |
| 5 | Industrials | 10.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
476
Bio-Techne
TECH
$8.42B
| $208M | 0.05% |
1,919,744
-39,872
| -2% | -$4.32M |
|
477
Hewlett Packard
HPE
$31.5B
| $208M | 0.05% |
12,436,577
-3,878,173
| -24% | -$64.8M |
|
478
Stellantis
STLA
$25.8B
| $207M | 0.05% |
12,751,791
-500,327
| -4% | -$8.14M |
|
479
CDW
CDW
$22B
| $207M | 0.05% |
1,158,069
+68,237
| +6% | +$12.2M |
|
480
Invesco Fundamental High Yield Corporate Bond ETF
PHB
$353M
| $207M | 0.05% |
11,260,891
-249,869
| -2% | -$4.59M |
|
481
Revvity
RVTY
$10B
| $206M | 0.05% |
1,180,717
+22,532
| +2% | +$3.93M |
|
482
Telus
TU
$25B
| $205M | 0.05% |
7,841,240
+192,511
| +3% | +$5.03M |
|
483
Copart
CPRT
$46.5B
| $205M | 0.05% |
6,522,220
-1,725,092
| -21% | -$54.1M |
|
484
Dover
DOV
$24.4B
| $204M | 0.05% |
1,303,222
+90,843
| +7% | +$14.3M |
|
485
Moody's
MCO
$91B
| $204M | 0.05% |
604,243
-150,205
| -20% | -$50.7M |
|
486
Brown-Forman Class B
BF.B
$13B
| $203M | 0.05% |
3,032,800
+307,388
| +11% | +$20.6M |
|
|
WRK
487
DELISTED
WestRock Company
WRK
| $203M | 0.05% |
4,318,971
-428,234
| -9% | -$20.1M |
|
488
Invesco FTSE RAFI US 1000 ETF
PRF
$8.11B
| $203M | 0.05% |
5,939,960
-376,420
| -6% | -$12.9M |
|
489
Zebra Technologies
ZBRA
$15.9B
| $203M | 0.05% |
489,991
-220,793
| -31% | -$91.3M |
|
490
Olin
OLN
$2.91B
| $202M | 0.05% |
3,873,113
-518,734
| -12% | -$27.1M |
|
491
HubSpot
HUBS
$26.5B
| $202M | 0.05% |
425,380
-258,867
| -38% | -$123M |
|
492
Cleveland-Cliffs
CLF
$5.35B
| $202M | 0.05% |
6,266,594
-1,044,592
| -14% | -$33.6M |
|
493
Darden Restaurants
DRI
$24.7B
| $201M | 0.05% |
1,512,345
+240,195
| +19% | +$31.9M |
|
494
Dentsply Sirona
XRAY
$2.77B
| $201M | 0.05% |
4,084,016
-368,514
| -8% | -$18.1M |
|
495
Biogen
BIIB
$21.1B
| $201M | 0.05% |
954,409
-176,654
| -16% | -$37.2M |
|
496
Nektar Therapeutics
NKTR
$924M
| $201M | 0.05% |
2,482,036
+22,603
| +0.9% | +$1.83M |
|
497
Omnicell
OMCL
$1.49B
| $200M | 0.05% |
1,546,313
+224,789
| +17% | +$29.1M |
|
498
NRG Energy
NRG
$29.5B
| $198M | 0.05% |
5,172,071
-249,747
| -5% | -$9.58M |
|
499
Bio-Rad Laboratories Class A
BIO
$7.86B
| $198M | 0.05% |
352,100
+35,635
| +11% | +$20.1M |
|
500
Boston Properties
BXP
$11.5B
| $197M | 0.05% |
1,529,693
+125,874
| +9% | +$16.2M |
|